CALITHERA BIOSCIENCES INC's ticker is CALA and the CUSIP is 13089P101. A total of 95 filers reported holding CALITHERA BIOSCIENCES INC in Q2 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $374,000 | +544.8% | 154,533 | +1207.1% | 0.00% | – |
Q4 2020 | $58,000 | -45.3% | 11,823 | -61.5% | 0.00% | -100.0% |
Q3 2020 | $106,000 | -38.4% | 30,690 | -20.9% | 0.00% | -75.0% |
Q1 2020 | $172,000 | -70.5% | 38,790 | -62.0% | 0.00% | +33.3% |
Q4 2019 | $583,000 | +322.5% | 102,094 | +189.2% | 0.00% | +200.0% |
Q2 2019 | $138,000 | -50.5% | 35,306 | -33.7% | 0.00% | -66.7% |
Q3 2018 | $279,000 | -4.8% | 53,236 | -9.2% | 0.00% | -25.0% |
Q2 2018 | $293,000 | -31.7% | 58,631 | -14.0% | 0.00% | -42.9% |
Q1 2018 | $429,000 | -29.4% | 68,160 | -6.3% | 0.01% | -36.4% |
Q4 2017 | $608,000 | +34.8% | 72,756 | +139.3% | 0.01% | +22.2% |
Q2 2017 | $451,000 | +229.2% | 30,400 | +155.5% | 0.01% | +125.0% |
Q1 2017 | $137,000 | +80.3% | 11,900 | -49.1% | 0.00% | +33.3% |
Q4 2016 | $76,000 | -15.6% | 23,400 | +100.0% | 0.00% | -70.0% |
Q4 2015 | $90,000 | – | 11,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,426,702 | $5,072,000 | 4.00% |
BVF INC/IL | 7,299,331 | $15,256,000 | 0.57% |
TSP Capital Management Group, LLC | 463,500 | $969,000 | 0.32% |
Tibra Equities Europe Ltd | 158,500 | $331,000 | 0.10% |
Parkman Healthcare Partners LLC | 100,628 | $210,000 | 0.05% |
SILVERARC CAPITAL MANAGEMENT, LLC | 31,382 | $66,000 | 0.03% |
FEDERATED HERMES, INC. | 6,668,978 | $13,938,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 108,111 | $226,000 | 0.02% |
FRANKLIN STREET ADVISORS INC /NC | 133,580 | $279,000 | 0.02% |
XTX Topco Ltd | 31,242 | $65,000 | 0.02% |